News

Today, the Federal Health and Aged Care Minister announced the listing of Vumerity® (diroximel fumarate) on the Pharmaceutical Benefits Scheme (PBS) for the treatment of Australians living with relapsing remitting MS (RRMS).

National Pain Week (July 25 to 31) is an annual event coordinated by Chronic Pain Australia. Pain is one of the less recognised symptoms of multiple sclerosis but affects around two-thirds of the over 25,600 Australians living with the disease.

This year marks the 50th year of Multiple Sclerosis Australia, an organisation formed to drive awareness, research, and support for people with multiple sclerosis (MS).

As we mark our 50th year, it's deeply encouraging to look at how far we have come over the past five decades and acknowledge the great changes that have taken place to improve the quality of life for people living with MS.

Epidemiological research shows that MS in the Greater Hobart area is on the rise.

A new study seeks to understand the role of B cells and EBV in the development of MS.

In an attempt to unravel the complex genetics of MS, Australian researchers have generated stem cells from four adult family members with MS.

Even if math isn't your strength, you can still combine great food, amazing locations and make a real difference to MS research on the Kiss Goodbye to MS Tuscany Trek 2022. And the good news is, there's still time to sign up!

As MS Australia (MSA) celebrates its 50th anniversary, we must acknowledge the hard work and dedication of John Studdy who helped MSA to become what it is today.

May has been a fun-filled month with 19,467 people across Australia getting active to raise money to accelerate research into the prevention, treatments and ultimately a cure for multiple sclerosis.

World MS Day – held on May 30 each year – was a memorable one. For me, four events stood out. 

The MS Australia Clinical Trials Network is a central point of information for people interested in participating in clinical trials and research studies in MS.

By Associate Professor Des Graham, President, MS Australia - A new workplace and employment survey has provided further evidence that too many Australian workplaces are failing people living with Multiple Sclerosis and other health conditions, and falling well short of community expectations.

Despite the progress made thanks to MS research, the key to a cure is yet to be found for people like Cheryl. Donations will help fund vital research projects that will build critical knowledge of MS, aiming to prevent and ultimately cure MS.  

People with MS face significant employment-related challenges and understanding and preparing for these may improve later employment outcomes.

A new study confirms that the protective T cell immune response induced by COVID-19 vaccination is preserved in people treated with B cell depleting therapies for MS. This helps our understanding of how vaccinations and MS treatments affect each other.

MS Australia, the national peak body for people affected by multiple sclerosis (MS), has today congratulated Prime Minister Anthony Albanese MP and the incoming Labor Government, and reiterated its call for full and ongoing funding of the National Disability Insurance Scheme (NDIS).

With Monday, May 30 the start of the working week, our focus this World MS Day, is Employment and MS, including its important link to community connection.